Satsuma Pharmaceuticals, Inc.
STSADelisted Jun 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001692830
Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Satsuma Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +9 vs. Q2 2022
- Shares held
- 24.4M
- +1.68M (+7.4%) vs. Q2 2022
- Total value
- $146.7M
- +$52.5M (+55.7%) vs. Q2 2022
- New holders
- 14
- 10 more added
- Sold out
- 5
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 31 | $12.7M |
| Q4 2022 | 33 | $17.8M |
| Q3 2022 | 41 | $146.7M |
| Q2 2022 | 32 | $94.2M |
| Q1 2022 | 36 | $87.7M |
| Q4 2021 | 35 | $103.6M |
| Q3 2021 | 45 | $108.3M |
| Q2 2021 | 60 | $167.4M |
| Q1 2021 | 61 | $136.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Satsuma Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 5,914,252 | $35.5M | 0.76% | 00.0% | Unchanged |
| Commodore Capital LP | 3,711,286 | $22.3M | 3.58% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,142,958 | $18.9M | 0.94% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 2,929,195 | $17.6M | 0.34% | −15,060−0.5% | Reduced |
| TPG GP A, LLC | 1,885,939 | $11.3M | 0.19% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 1,714,046 | $10.3M | 0.16% | +1,714,046 | New |
| Vivo Capital, LLC | 1,232,394 | $7.39M | 0.82% | 00.0% | Unchanged |
| Vanguard Group Inc | 909,390 | $5.46M | 0.00% | +269,026+42.0% | Added |
| Ameriprise Financial Inc | 796,865 | $4.78M | 0.00% | +39,380+5.2% | Added |
| Dimensional Fund Advisors LP | 276,266 | $1.66M | 0.00% | +39,731+16.8% | Added |
| Morgan Stanley | 223,816 | $1.34M | 0.00% | −22,876−9.3% | Reduced |
| Barclays PLC | 218,902 | $1.31M | 0.00% | +16,424+8.1% | Added |
| Geode Capital Management, LLC | 191,445 | $1.15M | 0.00% | +26,707+16.2% | Added |
| Nan Fung Group Holdings Ltd | 177,900 | $1.07M | 0.68% | +35,000+24.5% | Added |
| BlackRock Inc. | 152,180 | $913.0K | 0.00% | +14,940+10.9% | Added |
| EAM Investors, LLC | 149,029 | $894.0K | 0.19% | +149,029 | New |
| Ikarian Capital, LLC | 136,059 | $815.0K | 0.41% | −517,389−79.2% | Reduced |
| Bridgeway Capital Management, LLC | 115,300 | $692.0K | 0.02% | −12,000−9.4% | Reduced |
| Walleye Capital LLC | 93,672 | $562.0K | 0.01% | −57,756−38.1% | Reduced |
| Caption Management, LLC | 90,000 | $539.0K | 0.09% | +90,000 | New |
| Simplex Trading, LLC | 67,823 | $406.0K | 0.02% | +67,823 | New |
| State Street Corp | 62,236 | $373.0K | 0.00% | +19,200+44.6% | Added |
| Millennium Management LLC | 62,116 | $373.0K | 0.00% | +62,116 | New |
| Northern Trust Corp | 42,269 | $254.0K | 0.00% | +4,334+11.4% | Added |
| Two Sigma Advisers, LP | 34,800 | $209.0K | 0.00% | −2,800−7.4% | Reduced |
| Bank of America Corp | 18,495 | $111.0K | 0.00% | +18,495 | New |
| Bank of New York Mellon Corp | 16,262 | $98.0K | 0.00% | +16,262 | New |
| Boothbay Fund Management, LLC | 11,968 | $72.0K | 0.00% | −52,872−81.5% | Reduced |
| Susquehanna International Group, LLP | 12,050 | $72.0K | 0.00% | +12,050 | New |
| Schonfeld Strategic Advisors LLC | 11,300 | $68.0K | 0.00% | −100−0.9% | Reduced |
| Two Sigma Investments, LP | 10,529 | $63.0K | 0.00% | −3,140−23.0% | Reduced |
| Marshall Wace, LLP | 10,123 | $61.0K | 0.00% | +10,123 | New |
| Virtu Financial LLC | 10,096 | $61.0K | 0.01% | +10,096 | New |
| Renaissance Technologies LLC | 10,000 | $60.0K | 0.00% | +10,000 | New |
| Citigroup Inc | 6,585 | $40.0K | 0.00% | −488−6.9% | Reduced |
| Advisor Group Holdings, Inc. | 1,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 134 | $1.00K | 0.00% | +16+13.6% | Added |
| Federated Hermes, Inc. | 100 | $1.00K | 0.00% | +100 | New |
| Tower Research Capital LLC (TRC) | 110 | $1.00K | 0.00% | +110 | New |
| BNP Paribas Arbitrage, SA | 59 | $354 | 0.00% | +59 | New |
| UBS Group AG | 27 | $0 | 0.00% | −17,567−99.8% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −150,954−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −46,998−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,319−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,109−100.0% | Sold out |